Pediatric Research of Charlottesville, LLC
Charlottesville, Virginia 22902
4 studies enrolling now · 22 studies all time
What they study most
Acute Otitis Externa, Acute Treatment of Migraine, Atopic Dermatitis, COVID-19, Child Development, Constipation - Functional, Lyme Disease, Measles, Measles-Mumps-Rubella+Chickenpox Vaccine, Meningococcal Vaccine, Mumps, Pediatric Migraine
Studies at this site
- Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine — Recruiting now
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
- Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents — Recruiting now
- A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children — Completed
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age — Starting soon
- A Study to Learn About How a New Pneumococcal Vaccine Works in Infants — Running, not enrolling
- A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants — Running, not enrolling
- Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children — Completed
- A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules — Completed
- Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants — Completed
- Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age — Completed
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
- A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. — Completed
- Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa — Completed
- Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants — Completed
- Lubiprostone in Children With Functional Constipation — Completed
- Growth and Tolerance of Infants Fed Formula for 16 Weeks — Completed
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation — Completed
- Lubiprostone for Children With Constipation — Completed
- A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis — Completed
- A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
- Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age — Completed